Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania

NCT ID: NCT01253967

Last Updated: 2015-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1234 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-02-29

Study Completion Date

2010-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this hospital based study is to estimate the proportion of rotavirus gastroenteritis in children \< 5 years of age in Romania.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study consist of a main study and a health economics study

Main study: The study will focus on three different groups of patients:

* Subjects who are hospitalised for acute gastroenteritis.
* Subjects who visit an emergency room for acute gastroenteritis.
* Subjects who have rotavirus positive laboratory results and developed acute gastroenteritis at least 48 hours after hospitalisation.

Health economics study: for a subset of subjects, additional economic data will be gathered by completing a questionnaire

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infections, Rotavirus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Subjects who are hospitalised for acute gastroenteritis

Collection of stool samples

Intervention Type PROCEDURE

Stool samples will be tested for the presence of rotavirus and a subset of rotavirus positive samples will be genotyped.

Health economics questionnaire

Intervention Type OTHER

For a subset of subjects, additional economic data will be gathered by completing a questionnaire

Group B

Subjects who visit an emergency room for acute gastroenteritis

Collection of stool samples

Intervention Type PROCEDURE

Stool samples will be tested for the presence of rotavirus and a subset of rotavirus positive samples will be genotyped.

Health economics questionnaire

Intervention Type OTHER

For a subset of subjects, additional economic data will be gathered by completing a questionnaire

Group C

Subjects who have rotavirus positive laboratory results and developed acute gastroenteritis at least 48 hours after hospitalisation.

Collection of stool samples

Intervention Type PROCEDURE

Stool samples will be tested for the presence of rotavirus and a subset of rotavirus positive samples will be genotyped.

Health economics questionnaire

Intervention Type OTHER

For a subset of subjects, additional economic data will be gathered by completing a questionnaire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Collection of stool samples

Stool samples will be tested for the presence of rotavirus and a subset of rotavirus positive samples will be genotyped.

Intervention Type PROCEDURE

Health economics questionnaire

For a subset of subjects, additional economic data will be gathered by completing a questionnaire

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A male or female child aged \< 5 years at the time of admission. A child becomes ineligible on the day of her/his fifth birthday.
* A subject, who during the study period:

* Is hospitalised for acute gastroenteritis Or
* Visits an emergency room for acute gastroenteritis Or
* Has rotavirus positive laboratory results and develops acute gastroenteritis at least 48 hours after hospitalisation

Exclusion Criteria

Not applicable
Maximum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

GlaxoSmithKline

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

GSK Clinical Trials

Role: STUDY_DIRECTOR

GlaxoSmithKline

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

GSK Investigational Site

Bucharest, , Romania

Site Status

GSK Investigational Site

Bucharest, , Romania

Site Status

GSK Investigational Site

Cluj-Napoca, , Romania

Site Status

GSK Investigational Site

Cluj-Napoca, , Romania

Site Status

GSK Investigational Site

Constanța, , Romania

Site Status

GSK Investigational Site

Craiova, , Romania

Site Status

GSK Investigational Site

Sibiu, , Romania

Site Status

GSK Investigational Site

Timișoara, , Romania

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Romania

References

Explore related publications, articles, or registry entries linked to this study.

Benea OE, Streinu-Cercel A, Dorobat C, Rugina S, Negrutiu L, Cupsa A, Duiculescu D, Chiriac C, Itu C, Prisacariu LJ, Iosif I. Efficacy and safety of darunavir (Prezista((R))) with low-dose ritonavir and other antiretroviral medications in subtype F HIV-1 infected, treatment-experienced subjects in Romania: a post-authorization, open-label, one-cohort, non-interventional, prospective study. Germs. 2014 Sep 1;4(3):59-69. doi: 10.11599/germs.2014.1057. eCollection 2014 Sep.

Reference Type DERIVED
PMID: 25276665 (View on PubMed)

Anca IA, Furtunescu FL, Plesca D, Streinu-Cercel A, Rugina S, Holl K. Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children below five years of age in Romania. Germs. 2014 Jun 2;4(2):30-40. doi: 10.11599/germs.2014.1053. eCollection 2014 Jun.

Reference Type DERIVED
PMID: 24967217 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

110436

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.